Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR2 and miR-34a
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR2 and miR-34a
Authors
Keywords
<em class="EmphasisTypeItalic ">Emodin</em>, Liver cancer, VEGFR2, miR-34a
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-11
DOI
10.1007/s10637-019-00777-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion
- (2018) Dai Fuhong et al. BMC CANCER
- Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
- (2018) Martijn R. Meijerink et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Metazoan MicroRNAs
- (2018) David P. Bartel CELL
- Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery
- (2018) Shuichiro Shiina et al. Canadian Journal of Gastroenterology and Hepatology
- Sorafenib: A Review in Hepatocellular Carcinoma
- (2017) Gillian M. Keating Targeted Oncology
- Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
- (2017) Hongping Xia et al. Cell Death & Disease
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery
- (2016) Yu Zou et al. Drug Design Development and Therapy
- World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015
- (2016) Shelley McGuire Advances in Nutrition
- Inhibitory effect of emodin on human hepatoma cell line SMMC-7721 and its mechanism
- (2015) X Zhang et al. African Health Sciences
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
- (2015) Xi Wang et al. CELLULAR SIGNALLING
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Blockade of Emodin on Amyloid-β 25–35-Induced Neurotoxicity in AβPP/PS1 Mice and PC12 Cells through Activation of the Class III Phosphatidylinositol 3-Kinase/Beclin-1/B-Cell Lymphoma 2 Pathway
- (2015) Yan-ping Sun et al. PLANTA MEDICA
- Emodin Suppresses Maintenance of Stemness by Augmenting Proteosomal Degradation of Epidermal Growth Factor Receptor/Epidermal Growth Factor Receptor Variant III in Glioma Stem Cells
- (2015) Jeongyub Kim et al. STEM CELLS AND DEVELOPMENT
- The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis
- (2015) Zhongmin Zou et al. OncoTargets and Therapy
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation
- (2015) Maria Angelica Cortez et al. Molecular Therapy-Nucleic Acids
- Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer
- (2015) Yukiharu Hiyoshi et al. PLoS One
- Quantification of Therapeutic miRNA Mimics in Whole Blood from Nonhuman Primates
- (2014) Kevin Kelnar et al. ANALYTICAL CHEMISTRY
- Emodin-Provoked Oxidative Stress Induces Apoptosis in Human Colon Cancer HCT116 Cells through a p53-Mitochondrial Apoptotic Pathway
- (2014) Mei-Juan Xie et al. Asian Pacific Journal of Cancer Prevention
- Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs
- (2014) Xuemei Jia et al. BREAST CANCER RESEARCH AND TREATMENT
- Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer
- (2014) C. L. Daige et al. MOLECULAR CANCER THERAPEUTICS
- Emodin Ameliorates Ethanol-Induced Fatty Liver Injury in Mice
- (2014) Ying Liu et al. PHARMACOLOGY
- In-Depth Analysis Shows Synergy between Erlotinib and miR-34a
- (2014) Jane Zhao et al. PLoS One
- Emodin up-regulates glucose metabolism, decreases lipolysis, and attenuates inflammation in vitro大黄素在体内上调糖代谢、减少脂解和抑制炎症反应
- (2014) Xiaoyan Zhang et al. Journal of Diabetes
- Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation
- (2014) Jun Ma et al. Biomed Research International
- Emodin induces human T cell apoptosis in vitro by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction
- (2013) Kai Qu et al. ACTA PHARMACOLOGICA SINICA
- An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins
- (2013) Aruljothi Subramaniam et al. APOPTOSIS
- Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway
- (2013) Wang Yaoxian et al. Cancer Cell International
- Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors
- (2013) Bilel Jelassi et al. CARCINOGENESIS
- Traditional Herbal Medicine: A Review of Potential of Inhibitory Hepatocellular Carcinoma in Basic Research and Clinical Trial
- (2013) Zhidong Wang et al. Evidence-based Complementary and Alternative Medicine
- Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERαInhibition
- (2013) Pao-Hsuan Huang et al. Evidence-based Complementary and Alternative Medicine
- Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth
- (2013) Tai-Lung Cha et al. MOLECULAR CARCINOGENESIS
- In Vitro and in Vivo Studies of the Inhibitory Effects of Emodin Isolated from Polygonum cuspidatum on Coxsakievirus B4
- (2013) Zhao Liu et al. MOLECULES
- Emodin induces cytotoxic effect in human breast carcinoma MCF-7 cell through modulating the expression of apoptosis-related genes
- (2013) Wing-Yan Li et al. PHARMACEUTICAL BIOLOGY
- Antitubercular and Antibacterial Activity of Quinonoid Natural Products Against Multi-Drug Resistant Clinical Isolates
- (2013) Diganta Dey et al. PHYTOTHERAPY RESEARCH
- Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway
- (2013) Zhiyu Wang et al. PLoS One
- MicroRNA-34a Enhances T Cell Activation by Targeting Diacylglycerol Kinase ζ
- (2013) Jinwook Shin et al. PLoS One
- Emodin elicits cytotoxicity in human lung adenocarcinoma A549 cells through inducing apoptosis
- (2013) Wing-Yan Li et al. INFLAMMOPHARMACOLOGY
- Management of HCC
- (2012) Carlos Rodríguez de Lope et al. JOURNAL OF HEPATOLOGY
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
- (2012) V J Craig et al. LEUKEMIA
- Emodin As an Effective Agent in Targeting Cancer Stem-Like Side Population Cells of Gallbladder Carcinoma
- (2012) Xin-xing Li et al. STEM CELLS AND DEVELOPMENT
- MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back
- (2012) Marek Mraz et al. Expert Review of Hematology
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
- (2011) N. B. Jamieson et al. CLINICAL CANCER RESEARCH
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Comparison of the Antioxidant and Transmembrane Permeative Activities of the DifferentPolygonum cuspidatumExtracts in Phospholipid-Based Microemulsions
- (2011) Mei-Hwa Lee et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Lipid regulation effects of Polygoni Multiflori Radix, its processed products and its major substances on steatosis human liver cell line L02
- (2011) Minjiang Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Hepatotoxicity or Hepatoprotection? Pattern Recognition for the Paradoxical Effect of the Chinese Herb Rheum palmatum L. in Treating Rat Liver Injury
- (2011) Jia-bo Wang et al. PLoS One
- Phosphorylated Smad2 in Advanced Stage Gastric Carcinoma
- (2010) Osamu Shinto et al. BMC CANCER
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
- (2010) J. F. Wiggins et al. CANCER RESEARCH
- Prevalence, Patterns, and Costs of Chinese Medicine Use Among Prostate Cancer Patients: A Population-Based Study in Taiwan
- (2010) Yi-Hsien Lin et al. INTEGRATIVE CANCER THERAPIES
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastasis mechanisms
- (2009) Thomas R. Geiger et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities
- (2009) M Mraz et al. LEUKEMIA
- Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003
- (2008) Lee-Chin Chang et al. BMC HEALTH SERVICES RESEARCH
- The Effect of Emodin on VEGF Receptors in Human Colon Cancer Cells
- (2008) Yingying Lu et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells
- (2008) Na Li et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started